A review of human and analogue insulin trials.

A review of human and analogue insulin trials.

A recent meta-analysis evaluated trials of the rapid-acting analogues insulin lispro and insulin aspart, performed before the introduction of the basal analogues, insulin glargine and insulin detemir. This article reviews the effect of rapid-acting and basal insulin analogues separately and in combi...

Bibliografski detalji
Glavni autor:	Gough, S
Format:	Journal article
Jezik:	English
Izdano:	2007

Slični predmeti

Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?
od: Felix Kulozik, i dr.
Izdano: (2013-08-01)

Does all the evidence say that insulin analogues are more effective than human insulins?
od: M.V. Neborachko, i dr.
Izdano: (2021-11-01)

Engineering of insulin receptor isoform-selective insulin analogues.
od: Tine Glendorf, i dr.
Izdano: (2011-01-01)

Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10.
od: Bo F Hansen, i dr.
Izdano: (2012-01-01)

Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
od: Elena Viktorovna Surkova
Izdano: (2013-03-01)

Safety and Efficacy of Modern Insulin Analogues
od: Hye Jin Yoo, i dr.
Izdano: (2013-06-01)

Análogos de insulina Insulin analogues
od: Manuel E. Licea Puig
Izdano: (2006-12-01)

Regular human insulins versus rapid-acting insulin analogues in children and adolescents with type 1 diabetes: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
od: Johanne Juul Petersen, i dr.
Izdano: (2025-01-01)

Insulin degludec is a new ultra-long-acting insulin analogue
od: Ivan Ivanovich Dedov, i dr.
Izdano: (2014-07-01)

Insulin analogues and cancer: a note of caution
od: Joseph A.M.J.L. eJanssen, i dr.
Izdano: (2014-05-01)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
od: Ivan Ivanovich Dedov, i dr.
Izdano: (2014-12-01)

Human versus Analogue Insulin for Youth with Type 1 Diabetes in Low-Resource Settings (HumAn-1): protocol for a randomised controlled trial
od: Éimhín Ansbro, i dr.
Izdano: (2025-01-01)

Insulin analogues versus human insulin in type 1 diabetes: direct and indirect meta-analyses of efficacy and safety
od: Andréia Cristina Conegero Sanches, i dr.
Izdano: (2013-09-01)

Current european regulatory perspectives on insulin analogues
od: Enzmann Harald G, i dr.
Izdano: (2011-07-01)

Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials.
od: Fernanda O Laranjeira, i dr.
Izdano: (2018-01-01)

Insulin-induced Lipoatrophy in a Patient on Insulin Analogue Therapy: a Case Report
od: Vesselina Yanachkova, i dr.
Izdano: (2020-09-01)

Cross-Reactivity of Insulin Immunoassays Important for Insulin Analogue Detection in Factitious Hypoglycaemia
od: Sachin K. Raj, i dr.
Izdano: (2024-06-01)

Modern approach to the evaluation of the pharmacokinetics and pharmacodynamics of biosimilar recombinant human insulin and insulin analogues in I phase clinical study
od: Irina A. Proskurina, i dr.
Izdano: (2016-07-01)

Successful management of type IV hypersensitivity reactions to human insulin analogue with injecting mixtures of biphasic insulin aspart and dexamethasone
od: Wei-Lun Wen, i dr.
Izdano: (2019-04-01)

Health Technology Assessment on Insulin Analogues: the Rapid Review of Second Type Studies
od: A Oliyaeemanesh, i dr.
Izdano: (2012-07-01)

Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
od: Karla F. S. Melo, i dr.
Izdano: (2019-01-01)

Treatment of Type 2 Diabetes with Biphasic Insulin Analogues
od: Ali A. Rizvi
Izdano: (2016-10-01)

Determination of the Biological Activity of Insulin and Its Analogues in Animals
od: P. V. Shadrin, i dr.
Izdano: (2023-07-01)

Comparative Study between the Glycemic Control of Human Insulin and Insulin analogue In Sample of Iraqi Type 1 Diabetic Children and Adolescents
od: Noor Wafaa Hashim, i dr.
Izdano: (2018-12-01)

Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use- compilation of reports from the past 20 years
od: Werner Haim, i dr.
Izdano: (2011-06-01)

COMPARATIVE STUDY OF INTERACTION OF SOME DOMESTIC HUMAN INSULIN SUBSTANCES AND ITS ANALOGUES WITH INSULIN RECEPTOR BY METHOD OF SURFACE PLASMON RESONANCE
od: I. N. Urakova, i dr.
Izdano: (2019-01-01)

Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials
od: Beng Leong Lim, i dr.
Izdano: (2023-02-01)

Insulin analogues: new therapies for type 2 diabetes mellitus.
od: Bethel, M, i dr.
Izdano: (2002)

Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil.
od: Fernanda O Laranjeira, i dr.
Izdano: (2016-01-01)

Modern Approaches to Determination of the Biological Activity of Insulin and Its Analogues
od: T. A. Batuashvili, i dr.
Izdano: (2019-06-01)

Systemically modeling the dynamics of plasma insulin insubcutaneous injection of insulin analogues for type 1 diabetes
od: Jiaxu Li, i dr.
Izdano: (2008-11-01)

Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
od: Eun Yeong Choe, i dr.
Izdano: (2012-06-01)

Downstream processing of recombinant human insulin and its analogues production from E. coli inclusion bodies
od: Yin Yin Siew, i dr.
Izdano: (2021-07-01)

Effect of human insulin and insulin analogue on some inflammatory markers and total antioxidant capacity in a sample of Iraqi type 1 diabetic children and adolescents
od: Noor Wafaa Hashim, i dr.
Izdano: (2022-04-01)

A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes
od: Chun-Ting Yang, i dr.
Izdano: (2021-02-01)

A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
od: Kristensen Peter, i dr.
Izdano: (2012-06-01)

Minimizing Mitogenic Potency of Insulin Analogues Through Modification of a Disulfide Bond
od: Shee Chee Ong, i dr.
Izdano: (2022-06-01)

Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
od: Jakobsen Marie, i dr.
Izdano: (2012-09-01)

Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
od: Armstrong, M, i dr.
Izdano: (2013)

Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss
od: Schmidt, W, i dr.
Izdano: (2009)